EMMA RUINSKY: Open Payments
NPI 1588990956 · ASTORIA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,667 in 35 payments from 12 companies in 2025. Trend: 2023 $2,002 · 2024 $1,441 · 2025 $1,667
Food & beverage: $1,552Consulting: $115
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 7 | $392 |
| Alkermes, Inc. | 4 | $306 |
| Otsuka America Pharmaceutical, Inc. | 5 | $233 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $150 |
| ABBVIE INC. | 5 | $129 |
| Janssen Scientific Affairs, LLC | 1 | $115 |
| Axsome Therapeutics, Inc. | 4 | $95 |
| Lundbeck LLC | 3 | $88 |
| E.R. Squibb & Sons, L.L.C. | 2 | $74 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $31 |
Products named: FANAPT, LYBALVI, REXULTI, VRAYLAR, ARISTADA, ABILIFY MAINTENA, SPRAVATO, Auvelity.
Industry payments across NY — which companies pay providers there.
